Costs of Breast Cancer Chemotherapy Regimes Differ Greatly in US, Study Reports

Costs of Breast Cancer Chemotherapy Regimes Differ Greatly in US, Study Reports
The cost of chemotherapy regimes for breast cancer (BC)  vary greatly in the United States, regardless of proven effectiveness, a University of Texas (UT) MD Anderson Cancer Center study reported. It advises physicians and patients to consider cost differences when choosing among chemotherapy options of similar efficacy — potentially lowering annual breast cancer care costs nationwide by as much as $1 billion. The findings, part of a poster presentation at the June meeting of the American Society of Clinical Oncology (ASCO)  in Chicago, were published recently online in the journal Cancer, in an article titled, “Estimating regimen-specific costs of chemotherapy for breast cancer: Observational cohort study.” "The costs of cancer care have been increasing dramatically, both for the health care system and for patients. As physicians, we increasingly recognize the financial burden on our patients," Sharon Giordano, MD, lead author of the study and chair of Health Services Research and professor of Breast Medical Oncology, said in a press release. "Both physicians and patients need greater access to information about the treatment costs so this critical issue can be discussed during a patient's decision-making process." "This is especially relevant for breast cancer care,
Subscribe or to access all post and page content.

Leave a Comment

Your email address will not be published. Required fields are marked *

This site uses Akismet to reduce spam. Learn how your comment data is processed.